Ocular Therapeutix, Inc. (NASDAQ: OCUL) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $17.00 price target on the stock.
Why Ocular Therapeutix Was Bumping Higher This Week [Yahoo! Finance]
Ocular Therapeutix, Inc. (NASDAQ: OCUL) is now covered by analysts at Needham & Company LLC. They set a "buy" rating and a $15.00 price target on the stock.
Ocular Therapeutix, Inc. (NASDAQ: OCUL) was given a new $19.00 price target on by analysts at JMP Securities.
Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)